AB036. Comparison of the effectiveness of gefitinib, erlotinib and afatinib in epidermal growth factor receptor mutated tumors of non-small cell lung cancer

The non-small cell lung cancer (NSCLC) accounts approximately 85% of lung cancers and includes predominantly adenocarcinomas, which is the most common type and squamous cell carcinomas. The treatment options include surgery, radiation therapy, and chemotherapy and the decision depends on the patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Papathanasiou, Maria, Lambaki, Sofia, Porpodis, Konstantinos, Spyratos, Dionysios, Tryfon, Stayros, Zarogoulidis, Paulos, Eleytheriadoy, Ellada, Kontakiotis, Theodoros
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Abstract
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159369/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados